Q3FY23 Preview: Apollo Hospitals Enterprise: Revenue seen at Rs 43,817 million, PAT at Rs 2,237 million

  • 09 Feb, 2023 |
  • 10:20 AM
  • Strong revenue growth, margin pressure expected

Result date: 14th February, 2023

Recommendation: Buy

Target price: Rs 5,150

Apollo Hospitals Enterprise could post revenue growth of 20% over the year-ago quarter and 3% sequentially. Store addition and higher sales from existing stores could drive strong growth in pharmacy revenue.

EBITDA margin though could decline both over the year-ago quarter and sequentially during the quarter. Analysts at IIFL Securities expect Apollo’s growth momentum to sustain across all verticals, thereby leading to 17% EBITDA CAGR for the company over FY22-25.

Profit After Tax (PAT) could decline 2% over the year-ago quarter, but grow 10% sequentially.

Important management insights to watch out for:

  • Update on stake dilution in Healthco
  • Momentum of services provided on online Apollo 24/7 platform

December 2022 estimates

YoY change

QoQ change

Revenue (Rs mn)




EBITDA (Rs mn)




EBITDA margin 


(318) bps

(35) bps

Profit After Tax (Rs mn)




Source: IIFL Research


Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
ad IconAd Image

Most Read News

Article Image
  • 14 March, 2022 |
  • 7:03 AM

The US Federal committee's meeting will conclude on March 16, 2022.

Most Shared News

No Record Found